Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2017, Vol. 44 Issue (1): 133-134    DOI: 10.12891/ceog3313.2017
Case Report Previous articles | Next articles
Sympathetic neural hyperalgesia edema syndrome as a cause of autoimmune hearing loss
J.H. Check1, 2, *()
1 Cooper Medical School of Rowan University, Camden, NJ, USA
Cooper Institute for Reproductive and Hormonal Disorders, P.C., Mt. Laurel, NJ, USA
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
Purpose: To describe another previous unreported manifestation of the sympathetic neural hyperalgesia edema syndrome – autoimmune hearing loss. Materials and Methods: Dextroamphetamine sulfate 30 mg extended release capsules was given to a woman to try to help her conceive since, with her pelvic pain, chronic fatigue syndrome, and diarrhea, it was thought that an inflammatory condition related to permeation of unwanted chemicals into endometrial tissue related to the sympathetic neural hyperalgesia edema syndrome could be inhibiting her failure from conceiving despite three cycles of embryo transfer. Results: Not only did the symptoms mentioned above disappear, but she also noted marked improvement of hearing loss that had been present for several years. The improvement in hearing was documented by audiology tests and had not responded to many months of 15 mg/day prednisone. Conclusions: Autoimmune hearing loss (diagnosis established by her ear nose and throat specialist) should be added to the long list of manifestation of the sympathetic neural hyperalgesia edema syndrome.
Key words:  Autoimmune hearing loss      Autoimmune inner ear disease      Sympathetic neural hyperalgesia edema syndrome      Pelvic pain      Chronic fatigue     
Published:  10 February 2017     
*Corresponding Author(s):  J.H. CHECK     E-mail:  laurie@ccivf.com

Cite this article: 

J.H. Check. Sympathetic neural hyperalgesia edema syndrome as a cause of autoimmune hearing loss. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(1): 133-134.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog3313.2017     OR     https://ceog.imrpress.com/EN/Y2017/V44/I1/133

[1] Anjeza Xholli, Anna Biasioli, Giovanni Grandi, Angelo Cagnacci. Dienogest-based hormonal contraception induced changes in the ultrasound presentation of the uterus and menstrual pain[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1186-1192.
[2] Maria Aparecida Mazzutti Verlangieri Carmo, Helmer Herren, Francisco J. C. Dos-Reis, Fabricio Da Silva Costa, Julio C. Rosa-e-Silva, Antonio Alberto Nogueira, Omero Benedicto Poli-Neto. Reliability and agreement of three-dimensional/four-dimensional transperineal ultrasound in women with chronic pelvic pain[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 494-499.
[3] H.K. Kim, S.H. Park, C.J. Kim, J.Y. Kwon, J. Namkung. Large nabothian cyst with chronic pelvic pain: case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 1-3.
[4] G. Jarząbek-Bielecka, M. Mizgier, M. Chuchracki, M. Pisarska-Krawczyk, E. Jakubek, W. Kędzia. Lower abdominal pain as a problem in child gynecology[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 4-6.
[5] J.H. Check, M.P. Dougherty. Use of sympathomimetic amines to correct premenstrual urticaria and anaphylaxis[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 309-312.
[6] S. Morino, M. Ishihara, F. Umezaki, H. Hatanaka, M. Yamashita, T. Aoyama, M. Takahashi. Pelvic alignment risk factors associated with sacroiliac joint pain during pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(6): 850-854.
[7] S. Hamadeh, B. Addas, N. Hamadeh, J. Rahman. Succenturiate placenta - abruption in a young primigravida: an unusual presentation[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(5): 789-790.
[8] H. Göksever Çelik, G. Yetkin Yildirim, L.S. Türkgeldi. Is there any risk for recurrence after the first operation of imperforate hymen?[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 307-309.
[9] J.H. Check, A. Jaffe. Dextroamphetamine sulfate provided quick relief of severe post-partum depression that was recalcitrant to standard antidepressants and psychotherapy[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(2): 272-274.
[10] R. M. F. Daher, J. C. Rosa-e-Silva, O. B. Poli-Neto, F. J. Candido-dos-Reis, A. A. Nogueira. Diagnosis of endometriosis in women with chronic pelvic pain[J]. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(4): 512-515.
[11] J.H. Check. Chronic unremitting lower abdominal pain quickly abrogated following treatment with amphetamine[J]. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(1): 109-111.
[12] J.H. Check. Increased tissue permeability and sympathetic nervous system hypofunction may be the common link between dysmenorrhea, chronic pelvic pain, Mittelschmerz, and Crohn’s disease[J]. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(1): 112-113.
[13] A. A. Rouzi, N. Sahly, S. Kafy, D. Sawan, H. Abduljabbar. Prevalence of endometriosis at a university hospital in Jeddah, Saudi Arabia[J]. Clinical and Experimental Obstetrics & Gynecology, 2015, 42(6): 785-786.
[14] J. M. Rhymes, T. Gorman, R. A. Sasso. Mature cystic teratoma of both the fallopian tube and contralateral ovary: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2015, 42(6): 812-813.
[15] J.H. Check, A. Jaffe. Resolution of pelvic pain related to adenomyosis following treatment with dextroamphetamine sulfate[J]. Clinical and Experimental Obstetrics & Gynecology, 2015, 42(5): 671-672.
No Suggested Reading articles found!